Alert Data News | Business | Companies | UK | Chemicals, Pharmaceuticals, Biotechnology

AstraZeneca PLC

Fri, 30 Jul 2010 00:10:24 +0100

AstraZeneca gives investors a boost
AstraZeneca cheered investors as it doubled the value of its share buyback scheme, raised its full-year profits forecast and confirmed that a key new drug was close to being approved.

AstraZeneca PLC

Thu, 29 Jul 2010 23:22:01 +0100

AstraZeneca PLC

Thu, 29 Jul 2010 20:22:02 +0100

AstraZeneca's good results boosted by US backing for Brilinta
Blood-thinning treatment is given green light in America as profits forecast rises

Imperial Chemical Industries (ICI) PLC

Thu, 29 Jul 2010 16:57:09 +0100

DJ Imp. Chemical Inds. FRN Variable Rate Fix
TIDM57CT As Agent Bank, please be advised of the following rate determined on: 28/07/10 Issue ¦ Imperial Chemical Industries plc - Series 46 - US$ 30,000,000 (MTN) FRN due 29/10/2010 ISIN Number ¦ XS0...

London Stock Exchange Group PLC

Thu, 29 Jul 2010 16:52:21 +0100

FRN Variable Rate Fix - London Stock Exchange
Imperial Chemical Industries Ltd

Byotrol Plc

Thu, 29 Jul 2010 16:00:03 +0100

Byotrol Plc - Result of AGM
BYOT - leading AIM listed anti-microbial hygiene company, is pleased to announce that all resolutions put to shareholders at today's annual general meeting were duly passed. Enquiries: Byotrol plc ...

AstraZeneca PLC

Thu, 29 Jul 2010 15:00:01 +0100

AstraZeneca PLC - Directorate Change
AZN - NEW NON-EXECUTIVE DIRECTOR AstraZeneca today announced that Dr Bruce Burlington is to join the Board of Directors as a Non-Executive Director, with effect from 1 August 2010. Dr Burlington will also become a member of the Board's Science Committee. Dr Burlington spent 17 years of his ...

AstraZeneca PLC

Thu, 29 Jul 2010 13:21:55 +0100

Strong quarter for AstraZeneca as FDA panel backs Brilinta
AstraZeneca shares are on the rise this morning after the firm posted a strong set of financials for the second quarter and celebrated a recommendation for approval from US advisory panel for its bloo...

AstraZeneca PLC

Thu, 29 Jul 2010 13:21:34 +0100

AstraZeneca strong performer
Turning to larger companies AstraZeneca is a strong performer. The groupâ€™s potential blockbuster heart drug Brilinta has received the backing of a US advisory panel.

BASF Plc

Thu, 29 Jul 2010 11:21:16 +0100

Chemicals maker BASF sees Q2 earnings triple
Second-quarter profits at BASF SE more than tripled as a recovering global economy boosted demand and industry restocked inventories after the recession, the chemicals company said...